
1. antimicrob agents chemother. 2012 may;56(5):2511-7. doi: 10.1128/aac.05388-11.
epub 2012 feb 6.

comparative efficacies artemisinin combination therapies plasmodium
falciparum malaria polymorphism pfatpase6, pfcrt, pfdhfr, pfdhps genes
in tea gardens jalpaiguri district, india.

saha p(1), guha sk, das s, mullick s, ganguly s, biswas a, bera dk, chattopadhyay
g, das m, kundu pk, ray k, maji ak.

author information: 
(1)calcutta school tropical medicine, kolkata, india.

in india, chloroquine replaced combination artesunate and
sulfadoxine-pyrimethamine (as-sp) uncomplicated p. falciparum malaria. 
available combinations, artemether-lumefantrine (am-lf) artesunate-mefloquine
(as-mq), included national program, widely used private
practitioners. little known therapeutic efficacy these
artemisinin combinations prevalence molecular markers associated 
antimalarial drug resistance. total 157 patients p. falciparum
monoinfection recruited randomized three study groups (as-sp,
am-lf, as-mq). patients followed 42 days study the
clinical parasitological responses according protocol (2009). we
assessed polymorphism pfatpase6, pfcrt, pfdhfr, pfdhps genes by
the dna-sequencing method. pcr-corrected therapeutic efficacies as-sp,
am-lf, as-mq 90.6% (95% confidence interval [ci], 0.793 0.969), 95.9%
(95% ci, 0.860 0.995), 100% (95% ci, 0.927 1.00), respectively. no
specific mutational pattern observed pfatpase6 gene. isolates 
a k76t mutation pfcrt gene. pfdhfr-pfdhps genotype, quadruple
mutation frequent, quintuple mutation documented 6.3% p.
falciparum isolates. significant failure rate as-sp (9.5%), although
within limit (10%) drug policy change, due sp failure of
prevailing mutations pfdhfr, i(51)r(59)n(108), pfdhps, g(437) and/or
e(540). efficacy act needs periodic monitoring.
artemether-lumefantrine artesunate-mefloquine effective alternatives to
the artesunate-sulfadoxine-pyrimethamine combination.

doi: 10.1128/aac.05388-11 
pmcid: pmc3346630
pmid: 22314538  [indexed medline]

